Anja Schiel

Medical Products Agency — Sweden

Economics, Econometrics and Finance · Social Sciences

16h-index984citations43works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(27), Statistical Methods in Clinical Trials(12), Pharmaceutical Economics and Policy(9), Biomedical Ethics and Regulation(6), Economic and Financial Impacts of Cancer(5)

Publications42 total

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
The Lancet Oncology·2025· 5 citedOpen Access
Legal framework and challenges for drug repurposing in Europe
2025Open Access
Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics
The Lancet Oncology·2025· 1 citedOpen Access
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions
The Lancet Oncology·2025· 4 citedOpen Access
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop
The Lancet Oncology·2025· 13 citedOpen Access
Handling missing values in patient-reported outcome data in the presence of intercurrent events
BMC Medical Research Methodology·2025· 5 citedOpen Access
Time Delay
Alzheimer Disease & Associated Disorders·2025Open Access
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers
JAMA Network Open·2024· 2 citedOpen Access
The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology
BMC Medical Research Methodology·2024· 7 citedOpen Access
Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey
Health Policy and Technology·2024· 6 citedOpen Access
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy
Health Research Policy and Systems·2024· 8 citedOpen Access
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
Journal of Market Access & Health Policy·2024· 7 citedOpen Access
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
European Journal of Cancer·2023· 7 citedOpen Access
The role of stakeholder involvement in the evolving EU HTA process: <i>Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire</i>
Journal of Market Access & Health Policy·2023· 13 citedOpen Access
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
The Lancet Oncology·2023· 16 citedOpen Access
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs
Clinical Pharmacology & Therapeutics·2023· 6 citedOpen Access
Commentary on “Target estimands for population‐adjusted indirect comparisons”
Statistics in Medicine·2022· 6 cited
Generating the right evidence at the right time: Principles of a new class of flexible augmented clinical trial designs
arXiv (Cornell University)·2022Open Access
A framework for assessing the impact of accelerated approval
PLoS ONE·2022· 6 citedOpen Access
Estimands and Complex Innovative Designs
Clinical Pharmacology & Therapeutics·2022· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jaap C. Reijneveld(7), Peter G. M. Mol(7), Joseph C. Cappelleri(6), Martin Posch(5), Olivier Collignon(5), Khadija Rantell(5), Willi Sauerbrei(5), Cecilie Delphin Amdal(5), Ahu Alanya(5), Ragnhild Sørum Falk(5), Mallorie H. Fiero(5), Antoine Regnault(5), Satrajit Roychoudhury(5), Els Goetghebeur(5), Saskia le Cessie(5), Paul G. Kluetz(5), Michael Schlichting(5), Carl‐Fredrik Burman(4), Limin Liu(4), Doranne Thomassen(4)